Dr Reddy's Labs share closed 5.69% or Rs 277 lower at Rs 4,598 against previous close of Rs 4,876 on BSE

Dmitriev said Sputnik V's $10 price tag is not only affordable but also half to one-third of other vaccines and has an efficacy rate of more than 90 per cent

Stocks to watch today on January 18: HCL Tech, InterGlobe Aviation, SpiceJet, Vedanta, Wipro, DHFL, JBM Auto among others are the top stocks to watch out for in Monday's trading session

The goal of COVAX is to deliver two billion doses of safe, effective vaccines that have passed regulatory approval and/or WHO prequalification by the end of 2021

Centre had approved a four per cent DA hike for Central government employees in March 2020. However, in April, the hike was put on pause till July 1, 2021, due to the COVID-19 pandemic

Retail inflation decreased to 6.93% in Nov from 7.61% in Oct; Russia's Sputnik V shows 91.4% efficacy; Gmail, YouTube, other Google services back after massive global outage. Watch this and more news on News Blast.

Gmail, YouTube, other Google services back after massive global outage Google services including YouTube and Gmail are back after an outage that lasted close to an hour. Users worldwide are now reporting that the services of the tech giant have resumed functionality. YouTube was apparently the last service to have had its glitch rectified, while services like Gmail were reportedly brought back to normalcy faster. COVID-19 vaccine: Russia's Sputnik V shows 91.4% efficacyRussia's Sputnik V...

Stocks to watch today on December 2: ICICI Bank, YES Bank, Dr Reddy, Wockhardt, Ajanta Pharma, Coal India, Vodafone among others are the top stocks to watch out for in Wednesday's trading session

There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute

The announcement that comes a day after Oxford-Astrazeneca announced a similar level of efficacy for its COVID-19 vaccine allows India to hope for two vaccines to fight the COVID-19 pandemic in the country

Bharat Biotech has started the phase- 3 trial of its potential COVID-19 vaccine, involving 26,000 volunteers this month across 25 centres in the country, including Hyderabad, Goa, Nagpur, Bhubaneswar, and Aligarh

Online supermarket BigBasket landed in a soup recently when it accidentally put the data of over 2 crore users at stake.

Retail cheque payments fall to 2.96% in FY20 amid digitisation push: RBI; Develop COVID vaccine delivery system akin to polls, disaster management: PM Modi; Digital media, news agencies given a year to comply with 26% FDI cap. Watch this and more news on News Blast.Also Read: Gold price trades flat for second day; silver rates at Rs 61,500

Reliance Jio plans to sells 5G smartphones at Rs 2,500-3,000Reliance Jio is planning to launch a 5G smartphone for less than Rs 5,000 and gradually reduce the price to Rs 2,500-3,000 a unit when it scales up the operation, according to a company official. The company will target 20-30 crore mobile phone users who use 2G connection at present.Coronavirus impact: Passenger vehicle exports dip 57.52% in Apr-SepPassenger vehicle exports bore the brunt of the pandemic in April-September period....

Stocks to watch today on October 19: HDFC Bank, Tata Communications, Avenue Supermarts, Bajaj Consumer, RIL among others are the top stocks to watch out for in Monday's trading session

Coronavirus vaccine: While there are no intranasal COVID-19 vaccines under trial in India at the moment, the two companies will pursue clinical trials of such vaccines in India in the coming months

Dr Reddy's Lab share touched an intraday high of Rs 4651.95, a rise of 4.7% on BSE

While, Russian President Vladimir Putin and other officials have said that the coronavirus vaccine is completely safe, the country's decision to grant approval to it even before the final trial has raised concerns